Skip to content

TNYA

Tenaya Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$0.82+0.15%

Price as of Jul 20, 2026

TNYA capital

Tenaya Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.10x
Net debt / equity
-0.67x
Debt / assets
0.07x
Debt / EBITDA
-0.13x
Net debt / EBITDA
0.94x

Liquidity & coverage

Current ratio
5.75x
Quick ratio
5.75x
Cash ratio
4.82x
Interest coverage
EBITDA / interest
Working capital
$79.8M

Cash & dividend

FCF / debt
-6.39x
Cash flow / debt
-6.36x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.